Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoyin Jiaonang is a Traditional Chinese Medicine (TCM) herbal formulation developed and marketed by Shaanxi Momentum Pharmaceutical for the treatment of psoriasis. Formulated as an oral capsule, it is specifically indicated for psoriasis cases categorized under TCM patterns of blood heat or blood deficiency with wind-dryness, presenting symptoms such as bright red skin lesions and itching. The therapeutic mechanism, according to traditional theory, involves clearing heat to cool the blood, nourishing the blood to moisten dryness, and dispelling wind to alleviate itching. As a complex herbal product, it does not have a single defined Western molecular target but is recognized as an approved pharmaceutical product in the Chinese market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaoyin Jiaonang.